Cargando…

Simvastatin ameliorates glomerulosclerosis in Adriamycin-induced-nephropathy rats

The aim of this study was to investigate the effects of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, on inflammation and glomerulosclerosis in Adriamycin (ADR)-induced nephropathy. Male Sprague-Dawley rats were randomly divided into control, ADR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Li, Qiu, Wang, Lijia, Yang, Xiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2008
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811526/ https://www.ncbi.nlm.nih.gov/pubmed/18791746 http://dx.doi.org/10.1007/s00467-008-0933-8

Ejemplares similares

Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
por: Takiue, Keiichi, et al.
Publicado: (2012)

Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
por: Mansouri, Esrafil, et al.
Publicado: (2018)

Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats
por: Wang, Shu-Zhi, et al.
Publicado: (2015)

Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
por: Dai, Rufeng, et al.
Publicado: (2019)

ATRA attenuate proteinuria via downregulation of TRPC6 in glomerulosclerosis rats induced by adriamycin
por: Zhang, Lei, et al.
Publicado: (2018)

Ameliorating Effect of Gemigliptin on Renal Injury in Murine Adriamycin-Induced Nephropathy
por: Kim, Da Rae, et al.
Publicado: (2017)

Salidroside ameliorates Adriamycin nephropathy in mice by inhibiting β‐catenin activity
por: Huang, Xinzhong, et al.
Publicado: (2019)

Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy
por: Kim, Hyung Sook, et al.
Publicado: (2019)

Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy
por: Wang, Na, et al.
Publicado: (2016)

Serum Metabolic Profiling in a Mouse Model of Adriamycin-Induced Focal Segmental Glomerulosclerosis
por: Lyu, Li, et al.
Publicado: (2018)

Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis
por: Zhuang, Qiyuan, et al.
Publicado: (2020)

CTLA4-Ig Abatacept Ameliorates Proteinuria by Regulating Circulating Treg/IL-17 in Adriamycin-Induced Nephropathy Rats
por: Shuai, Lanjun, et al.
Publicado: (2020)

Neph1 Is Reduced in Primary Focal Segmental Glomerulosclerosis, Minimal Change Nephrotic Syndrome, and Corresponding Experimental Animal Models of Adriamycin-Induced Nephropathy and Puromycin Aminonucleoside Nephrosis
por: Hulkko, Jenny, et al.
Publicado: (2014)

Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
por: Stangenberg, Stefanie, et al.
Publicado: (2018)

Epimedium sagittatum Maxim ameliorates adriamycin‐induced nephropathy by restraining inflammation and apoptosis via the PI3K/AKT signaling pathway
por: Wang, Ru, et al.
Publicado: (2023)

Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton
por: Yin, Lei, et al.
Publicado: (2017)

Inflammation Induces Lipid Deposition in Kidneys by Downregulating Renal PCSK9 in Mice with Adriamycin-Induced Nephropathy
por: Zhang, Gaofu, et al.
Publicado: (2019)

Artemether ameliorates adriamycin induced cardiac atrophy in mice
por: Weng, Wenci, et al.
Publicado: (2023)

Histological study on the protective effect of endogenous stem-cell mobilization in Adriamycin-induced chronic nephropathy in rats
por: Sadek, Eman Mostafa, et al.
Publicado: (2016)

Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition
por: Handa, Takaya, et al.
Publicado: (2021)

Artemether ameliorates kidney injury by restoring redox imbalance and improving mitochondrial function in Adriamycin nephropathy in mice
por: Han, Pengxun, et al.
Publicado: (2021)

Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy
por: Sun, Yu Bo Yang, et al.
Publicado: (2013)

Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
por: Escribano, Begoña M., et al.
Publicado: (2014)

Experimental Study on the Mechanism of Cinnamaldehyde Ameliorate Proteinuria Induced by Adriamycin
por: He, Dan, et al.
Publicado: (2022)

Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis
por: Hu, Qiong-Dan, et al.
Publicado: (2023)

Correction: Impact of Light/Dark Cycle Patterns on Oxidative Stress in an Adriamycin-Induced Nephropathy Model in Rats
Publicado: (2014)

Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
por: Hong, Young Mi, et al.
Publicado: (2017)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy
por: Wong, May YW, et al.
Publicado: (2020)

Erratum to “Effect of Nephropathy Prescription I on the Expression of Angptl3 and Podocyte-Associated Protein in Mice with Adriamycin-Induced Nephropathy”
por: Zhang, Feifei, et al.
Publicado: (2023)

Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
por: Tan, Roderick J., et al.
Publicado: (2013)

Thrombospondin 1 Deficiency Ameliorates the Development of Adriamycin-Induced Proteinuric Kidney Disease
por: Maimaitiyiming, Hasiyeti, et al.
Publicado: (2016)

Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
por: Tian, Wenjie, et al.
Publicado: (2015)

The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Mason, P D
Publicado: (1997)

The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Milford, D V
Publicado: (1997)

JiaWeiDangGui Decoction Ameliorates Proteinuria and Kidney Injury in Adriamycin-Induced Rat by Blockade of TGF-β/Smad Signaling
por: Wei, Ming-gang, et al.
Publicado: (2016)

Ameliorating Adriamycin-Induced Chronic Kidney Disease in Rats by Orally Administrated Cardiotoxin from Naja naja atra Venom
por: Ding, Zhi-Hui, et al.
Publicado: (2014)

Low intensity pulsed ultrasound ameliorates Adriamycin-induced chronic renal injury by inhibiting ferroptosis
por: Ouyang, Zhi-Qiang, et al.
Publicado: (2023)

Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats
por: Tang, Lixia, et al.
Publicado: (2020)

Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy
por: Xie, Kewei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1u1tlqf4l33bn1bcksqhd0l2mq